Drs Taggart And Niquette P C Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 327 Apache Drive, Fremont, MI 49412 Phone: 231-924-5542 Fax: 231-924-5826 |
Drs Fair And Niquette Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 517 N Stone Rd, Suite 102, Fremont, MI 49412 Phone: 231-924-5542 Fax: 231-924-5826 |
Walter I. Coleman, Dds, Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 111 W Dayton St, Fremont, MI 49412 Phone: 231-924-3600 |
Fremont Dental Associates Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 111 W Dayton St, Fremont, MI 49412 Phone: 231-924-3600 Fax: 231-924-9720 |
Michael P Campeau, Dds, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 661 E Main St, Fremont, MI 49412 Phone: 231-924-2320 Fax: 231-924-1518 |
Prins Family Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 855 N Darling Ave, Fremont, MI 49412 Phone: 231-924-4650 |
News Archive
Functional psychosis can be diagnosed from the first indications of the patient, thanks to affective symptomatology. Depressive moods, hyperactivity and lack of concentration are affective symptoms that can present themselves during the first psychotic episodes, and the presence or absence of any of them may contribute to differentiating, at an early stage, between the different variations of the mental disease.
In their new paper available on the bioRxiv* preprint server, US researchers from the OpenBiome nonprofit organization used a mathematical model to simulate the usefulness of different testing strategies for fecal samples and showed that the probability of releasing a fecal microbiota donation with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is low when several important variables are taken into account.
The potentially debilitating condition known as gastroparesis, which results when stomach muscle contractions function abnormally, causing the stomach's contents to empty too slowly, affects as many as five million Americans
Food and Drug Administration policies prevent pharmaceutical manufacturers from informing patients about potentially fatal toxicities that occur with some cancer drugs - policies that should be revised immediately, according to Northwestern University researchers.
Pluristem Therapeutics Inc. today announced that safety and potential efficacy parameters were demonstrated by the three month follow up data from the first patient ever to receive its placenta derived cell therapy product, PLX-PAD. The patient is participating in a Phase I dose-escalating clinical trial in Europe with PLX-PAD, the company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
› Verified 4 days ago